2026-05-06

Gold +3.26% — significant rally

Oil -7.18% — significant selloff

Gold +3.07% — significant rally

Oil -7.24% — significant selloff

Gold +3.44% — significant rally

USDC/USDT has $202.3M volume but only $884K liquidity — thin market, slippage risk

BTC ETF inflow of $1171M — institutional buying

ETH ETF inflow of $820M — institutional buying

USDC/USDT has $231.7M volume but only $884K liquidity — thin market, slippage risk

BTC ETF inflow of $1257M — institutional buying

ETH ETF inflow of $820M — institutional buying

USDC/USDT has $216.4M volume but only $884K liquidity — thin market, slippage risk

FDA approves PAXLOVID (Pfizer) — new revenue stream

FDA approves GLUCOTROL XL (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves FRAGMIN (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves HALCION (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves CLEOCIN PHOSPHATE (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves FRAGMIN (Pfizer) — new revenue stream

FDA approves DICLOFENAC SODIUM AND MISOPROSTOL (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves DICLOFENAC SODIUM AND MISOPROSTOL (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves CLEOCIN PHOSPHATE (Pfizer) — new revenue stream

FDA approves PAXLOVID (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves GLUCOTROL XL (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves PAXLOVID (Pfizer) — new revenue stream

FDA approves GLUCOTROL XL (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves MEDROXYPROGESTERONE ACETATE (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves FRAGMIN (Pfizer) — new revenue stream

FDA approves MEDROXYPROGESTERONE ACETATE (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves MEDROXYPROGESTERONE ACETATE (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves DICLOFENAC SODIUM AND MISOPROSTOL (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves HALCION (Pfizer) — new revenue stream

FDA approves CLEOCIN PHOSPHATE (Pfizer) — new revenue stream

FDA approves drug (Pfizer) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Merck) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves HUMULIN N (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves HUMULIN N (Lilly) — new revenue stream

FDA approves HUMULIN N (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves HUMULIN R (Lilly) — new revenue stream

FDA approves HUMULIN R (Lilly) — new revenue stream

FDA approves HUMULIN R (Lilly) — new revenue stream

FDA approves drug (Lilly) — new revenue stream

FDA approves KRAZATI (Bristol) — new revenue stream

FDA approves KRAZATI (Bristol) — new revenue stream

FDA approves KRAZATI (Bristol) — new revenue stream

FDA approves ZEPOSIA 7-DAY STARTER PACK (Bristol) — new revenue stream

FDA approves ZEPOSIA 7-DAY STARTER PACK (Bristol) — new revenue stream

FDA approves ZEPOSIA 7-DAY STARTER PACK (Bristol) — new revenue stream

FDA approves SURVANTA (AbbVie) — new revenue stream

FDA approves SURVANTA (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves LEXAPRO (AbbVie) — new revenue stream

FDA approves LEXAPRO (AbbVie) — new revenue stream

FDA approves LEXAPRO (AbbVie) — new revenue stream

FDA approves NORVIR (AbbVie) — new revenue stream

FDA approves NORVIR (AbbVie) — new revenue stream

FDA approves NORVIR (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves DURYSTA (AbbVie) — new revenue stream

FDA approves DURYSTA (AbbVie) — new revenue stream

FDA approves DURYSTA (AbbVie) — new revenue stream

FDA approves ACULAR (AbbVie) — new revenue stream

FDA approves ACULAR (AbbVie) — new revenue stream

FDA approves ACULAR (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves ORIAHNN (AbbVie) — new revenue stream

FDA approves ORIAHNN (AbbVie) — new revenue stream

FDA approves ORIAHNN (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves URSO 250 (AbbVie) — new revenue stream

FDA approves URSO 250 (AbbVie) — new revenue stream

FDA approves URSO 250 (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves VIBERZI (AbbVie) — new revenue stream

FDA approves VIBERZI (AbbVie) — new revenue stream

FDA approves VIBERZI (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves LATISSE (AbbVie) — new revenue stream

FDA approves LATISSE (AbbVie) — new revenue stream

FDA approves LATISSE (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves drug (AbbVie) — new revenue stream

FDA approves SURVANTA (AbbVie) — new revenue stream

FDA approves drug (Abbott) — new revenue stream

FDA approves drug (Abbott) — new revenue stream

FDA approves drug (Abbott) — new revenue stream

FDA approves drug (Abbott) — new revenue stream

FDA approves drug (Abbott) — new revenue stream

FDA approves drug (Abbott) — new revenue stream

FDA approves drug (Abbott) — new revenue stream

FDA approves drug (Abbott) — new revenue stream

FDA approves drug (Abbott) — new revenue stream

FDA approves drug (Abbott) — new revenue stream

FDA approves drug (Abbott) — new revenue stream

FDA approves drug (Abbott) — new revenue stream

FDA approves drug (Abbott) — new revenue stream

FDA approves drug (Abbott) — new revenue stream